Todd Brady is listed as an executive officer and director on 5 SEC Form D filings by 3 issuers between Jun 2010 and Feb 2026: Avidity Biosciences, Inc. (San Diego, CA — biotechnology — 2017–2019; $400.2M reported sold to 45 investors), Hyperframe Inc. (Columbus, OH — manufacturing — 2022–2026; $18.3M reported sold to 37 investors) and Evoke Pharma Inc (San Diego, CA — biotechnology — 2010; $6M reported sold to 20 investors).
What this means A repeat sponsor — 3 separate companies raised money with this person listed as executive officer and director, over about 16 years. Across those companies the filings report $424.5M sold in total.
Listed alongside Jay F. Cady (2 shared filings), Ken Sobel (2 shared filings), Michael Martin (2 shared filings), Troy Wilson (2 shared filings), Alexandria Lafci (1 shared filing) and 13 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Todd. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), state securities regulators (AZ, CA, DE, TX, WA) — 5 bankruptcy cases matching the name listed in Key records below. Not yet searched: SEC enforcement releases (search queued; results are added automatically).
What this means 5 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.